Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]

Comment: New immunotherapy options for kidney cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium

Comment: New immunotherapy options for kidney cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

Tailoring treatment strategies in prostate cancer: expert insight

Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu

Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )

Tackling global radiotherapy shortfall could save millions of lives and boost...

Prof Rifat Atun - Harvard University, Boston, USA

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated...

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

CheckMate 025 trial results: Nivolumab versus everolimus in pre-treated advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

Everolimus for non-functional neuroendocrine tumours

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA

Everolimus for non-functional neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )

Nivolumab improves overall survival for advanced kidney cancer

Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA

Nivolumab improves overall survival for advanced kidney cancer ( Prof Padmanee Sharma - MD Anderson Cancer Center, Houston, USA )

EUROCARE-5 results show large variations in survival from blood cancers between...

Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy

EUROCARE-5 results show large variations in survival from blood cancers between European countries ( Dr Milena Sant - Istituto Nazionale Tumori, Milan, Italy )

METEOR trial results: Cabozantinib improves advanced kidney cancer survival

Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA

METEOR trial results: Cabozantinib improves advanced kidney cancer survival ( Prof Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )

Atrial fibrillation in CLL patients on ibrutinib

Prof Florence Cymbalista – University of Paris, Paris, France

Atrial fibrillation in CLL patients on ibrutinib ( Prof Florence Cymbalista – University of Paris, Paris, France )

Circulating levels of tumour DNA in plasma may help monitor treatment response...

Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )

Tumour specific immunotherapy in CLL

Prof Catherine Wu - Harvard Medical School, Boston, USA

Tumour specific immunotherapy in CLL ( Prof Catherine Wu - Harvard Medical School, Boston, USA )

Highlights from iwCLL 2015

Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia

Highlights from iwCLL 2015 ( Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia )

More from ecancer